Landon Ashby - Concepedia

Author

Landon Ashby

Kaiser Permanente ORCID

Also Known As

L Ashby, L S Ashby, L. Ashby, L. S. Ashby, L.S. Ashby, Landon Ashby, Landon S Ashby, N. A. Paleologos

Publications

518

Citations

H-Index

Concepts

All Affiliations

Kaiser Permanente University of Virginia Memorial Sloan Kettering Cancer Center St. Joseph's Hospital and Medical Center Albany Medical Center Hospital

About

Landon Ashby is an author at Kaiser Permanente specializing in medicine, neuropsychology, and behavioral sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	64
2	Health Sciences	1	1	22
3	Social Sciences	1	1	25
4	Behavioral Sciences	1	1	25
5	Neuroscience	1	1	25

Landon Ashby

Publications

485

Citations

H-Index

Page 1

	Year	Citations
International retrospective study of over 1000 adults with anaplastic oligodendroglial tumors A. B. Lassman, Fábio M. Iwamoto, Timothy F. Cloughesy, Neuro-Oncology	2011	170
Lamotrigine (BW430C), a potential anticonvulsant. Effects on the central nervous system in comparison with phenytoin and diazepam. AF Cohen, Landon Ashby, David C. Crowley, British Journal of Clinical Pharmacology	1985	142
Initial treatment patterns over time for anaplastic oligodendroglial tumors Katherine S. Panageas, Fábio M. Iwamoto, Timothy F. Cloughesy, Neuro-Oncology	2012	56
Intermediate-Risk Meningioma: Initial Outcomes from NRG Oncology/RTOG-0539 Leland Rogers, P. Zhang, Michael A. Vogelbaum, International Journal of Radiation OncologyBiologyPhysics Neuro-oncologyIntermediate-risk MeningiomaMedicineCancer ManagementOncology	2015	42
A comparison of methods for assessing the sedative effects of diphenhydramine on skills related to car driving AF Cohen, John Posner, Landon Ashby, European Journal of Clinical Pharmacology Behavioral SciencesNeuropsychologyCar DrivingDriver BehaviorDriver Performance	1984	25
Ongoing Clinical Trials Joanna Clarke, Marguerite Ennis, Kathleen R. Lamborn, Neuro-Oncology Clinical Trial ManagementClinical EndpointClinical TrialsRandomized Controlled TrialMedicine	2010	22
Recursive partitioning analysis of prognostic variables in newly diagnosed anaplastic oligodendroglial tumors Katherine S. Panageas, Anne S. Reiner, Fábio M. Iwamoto, Neuro-Oncology	2014	14
IT-30 * ReACT: A PHASE II STUDY OF RINDOPEPIMUT VACCINE (CDX-110) PLUS BEVACIZUMAB IN RELAPSED GLIOBLASTOMA David A. Reardon, James M. Schuster, D. Tran, Neuro-Oncology	2014	14

Page 1